Recent News About Hesperos and Human-on-a-Chip Technology

Hesperos’ Models Under Consideration to Address Opiod Crisis

By Hesperos | March 18, 2019 | 0 Comments

The interest in our human-on-a-chip model continues to grow.  Last week we brought our systems to the National Center for Translational Science (NCATS) at the NIH in Washington, D.C. to perform a real-time demo using live … Read More

Mice no more? Hesperos’ multi-organ “Human-on-a-Chip” System Found Effective for Long-Term Toxicology Testing

By Hesperos | March 1, 2019 | 0 Comments
lab tests

Collaboration between L’Oreal, Hesperos and UCF results in further reduction in reliance on animal testing in drug and cosmetics development (ORLANDO, Fla.) The replacement of animals as test subjects is one step closer to reality with … Read More

Hesperos at NCATS-NASA State-of-the-Science Meeting

By Hesperos | January 2, 2019 | 0 Comments

We’ve been forging new frontiers with our human-on-a-chip multi-organ models—could the next one take us into space?  Last month, we traveled to Washington, DC, to attend a workshop with officials from NASA,NCATS (National Center for Advancing … Read More

Spotlight on Hesperos Innovation at Florida Life Sciences Conference

By Hesperos | October 17, 2018 | 0 Comments

We were proud to join hundreds of Florida’s executives, scientists, researchers, investors, legislators, and service providers from the biopharmaceutical, medical device, and healthIT at the recent BioFlorida Annual Conference to celebrate Florida innovation and achievements — … Read More

Hesperos, Inc. Among GROWFL 2018 Florida Companies to Watch

By Hesperos | September 20, 2018 | 0 Comments

(ORLANDO, Fla.)  Hesperos, Inc. has announced that it has been named one of the 50 statewide companies expected to see significant growth over the next several years by GrowFL. The 50 companies were selected from more … Read More

Hesperos Human-on-a-Chip Technology Awarded $4 Million Phase IIb SBIR Grant – the first tissue chip company to receive Phase IIb grant

By Hesperos | September 6, 2018 | 0 Comments

ORLANDO, FLA – September 6, 2018 — Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center … Read More

Hesperos To Create Multi-Organ Human-On-A-Chip Model to Test Alzheimer’s Drugs

By Hesperos | August 31, 2018 | 0 Comments

Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute on Aging (NIA) to help create a new multi-organ “human-on-a-chip” … Read More